Allspring Global Investments Holdings, LLC - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$103,573
+22.1%
4,474
+38.1%
0.00%
Q4 2022$84,861
+30.6%
3,239
-2.1%
0.00%
Q3 2022$65,000
-66.5%
3,310
-72.2%
0.00%
Q4 2021$194,00011,9240.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 5,161,888$198,319,73734.81%
Saturn V Capital Management LP 524,811$20,163,23911.18%
Frazier Life Sciences Management, L.P. 4,345,559$166,956,3779.97%
Altium Capital Management LP 305,000$11,718,1008.87%
MPM BioImpact LLC 1,003,406$38,550,8597.76%
Affinity Asset Advisors, LLC 321,017$12,333,4734.31%
ALPINE ASSOCIATES MANAGEMENT INC. 2,131,000$81,873,0203.69%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,748,141$67,163,5773.59%
Nan Fung Group Holdings Ltd 113,950$4,377,9592.80%
Vivo Capital, LLC 934,879$35,918,0512.48%
View complete list of CHINOOK THERAPEUTICS INC shareholders